Victory Capital Management
BDSI

Victory Capital Management’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Victory Capital Management’s Portfolio BDSI Stock Details BDSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-254,643
Closed -$789K – 2889
2021
Q4 		$789K Buy
254,643
+94,502
+59% +$318K ﹤0.01% 1939
2021
Q3 		$578K Buy
160,141
+86,788
+118% +$327K ﹤0.01% 2098
2021
Q2 		$263K Buy
73,353
+25,647
+54% +$90.5K ﹤0.01% 2458
2021
Q1 		$187K Buy
47,706
+31,784
+200% +$131K ﹤0.01% 2532
2020
Q4 		$67K Buy
15,922
+1,000
+7% +$3.85K ﹤0.01% 2443
2020
Q3 		$56K Sell
14,922
-62,582
-81% -$266K ﹤0.01% 2383
2020
Q2 		$338K Buy
77,504
+48,534
+168% +$218K ﹤0.01% 2130
2020
Q1 		$110K Buy
28,970
+8,270
+40% +$40.6K ﹤0.01% 2513
2019
Q4 		$131K Buy
20,700
+6,063
+41% +$35.6K ﹤0.01% 2451
2019
Q3 		$62K Buy
+14,637
New +$62.5K ﹤0.01% 2595

Other funds holding BDSI

CAM
Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return
FCMT
Founders Capital Management (Texas) Houston, Texas $231M AUM 61.68% 1-Year Est. Return

Victory Capital Management's BDSI Position: Q1 2022 in Review

Victory Capital Management sold out of BioDelivery Sciences International, Inc. (BDSI) in Q1 2022, closing a stake of 254,643 shares — an estimated $789K sold.

Victory Capital Management first reported a position in BDSI in Q3 2019 and held it in 10 quarters. The position peaked at $789K in Q4 2021. 2 funds tracked by Wall St. Rank hold BDSI as of Q1 2022.

  • Victory Capital Management reported no remaining BioDelivery Sciences International, Inc. position as of Q1 2022 after selling out during the quarter.
  • Victory Capital Management sold 254,643 BioDelivery Sciences International, Inc. shares in Q1 2022, an estimated $789K.
  • Victory Capital Management first reported a position in BioDelivery Sciences International, Inc. in Q3 2019 and held it in 10 quarters.
  • Victory Capital Management's BioDelivery Sciences International, Inc. position peaked at $789K in Q4 2021.
  • 2 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2022.

Based on Victory Capital Management's 13F filing for Q1 2022, filed 4 May 2022.